Data centers test the durability of two small-cap growth stories
Stock Talk Podcast Episode 352
The episode weighs whether infrastructure demand can sustain Hammond Power’s expansion and whether ElectroMed can overcome concentration, management, and acquisition risks.
- 1Hammond Power’s transformer exposure links its growth to data centers and electrification, but valuation and sustainability remain central questions.
- 2ElectroMed combines strong margins and revenue growth with single-product concentration, slowing momentum, and leadership uncertainty.
- 3Disciplined organic growth and careful acquisition decisions emerge as more durable compounding drivers than debt-funded expansion.
Don't miss
The Hammond Power discussion crystallizes how data-center and electrification demand can support growth while valuation and sustainability still impose a test.
The brief
The conversation opens with Canada’s proposed Building Canada Strong Act, asking whether faster approvals and revised regulatory processes could shorten mining and infrastructure timelines.
Hammond Power becomes the clearest growth case: U.S. plant expansion, transformer demand, data-center construction, and electrification support the story, while valuation and long-term sustainability complicate it.
The hosts use Hammond Power to frame a broader investing lesson: steady earnings, cash flow, responsible per-share growth, and a later multiple re-rating can turn an overlooked business into a multibagger.
ElectroMed offers a sharper risk test, pairing strong margins and revenue growth with dependence on one SmartVest product, slowing momentum, a CEO departure, and acquisition uncertainty.
The closing contrast favors management continuity, disciplined acquisitions, and double-digit organic growth over debt-funded expansion that leaves interest costs and failed deals to damage earnings.
What was said on this episode
21 statements · 14 positive · 6 negative · 1 mixed
Bill C-39 is expected to advance through Canada’s legislative process.
“We expect it to move forward.”
Listen at 4:08
Bill C-39 would likely benefit mining companies advancing projects.
“Mining companies likely with projects looking to move forward.”
Listen at 4:53
Bill C-39 would likely benefit energy, midstream, and LNG projects.
“Energy and midstream companies, including some of the LNG projects that are looking to move forward.”
Listen at 4:57
Bill C-39 could potentially benefit nuclear and uranium companies.
“And potentially nuclear and uranium based companies.”
Listen at 5:03
Investors should favor solid infrastructure-exposed businesses regardless of project outcomes.
“we'll be looking for existing, good, solid businesses that have infrastructure exposure.”
Listen at 8:40
Investors should avoid indiscriminately buying infrastructure companies after sector surges.
“you probably don't want to be just buying all infrastructure related companies now as well”
Listen at 9:23
Hammond Power’s capacity utilization is projected to reach about 90% by 2028.
“By 2028, utilization is projected to be about 90%”
Listen at 15:41
Hammond Power’s multi-year business outlook remains strong.
“The multi-year outlook for Hammond Power remains strong.”
Listen at 19:54
Hammond Power’s valuation is elevated near term but more reasonable over the medium term.
“Valuations near term are elevated midterm. They're more reasonable.”
Listen at 20:31
Hammond Power revenue could reach approximately $1.7–$1.8 billion within three years.
“we could get to 1.7, 1.8 by, you know, the next three years, two, three years, depending on how they execute.”
Listen at 21:33
Electrification- or nuclear-exposed companies may receive valuation multiple expansion.
“they may get a multiple re-rating.”
Listen at 25:06
Companies should grow earnings or cash flow per share, not merely revenue.
“Not just top line growth. You got to grow the bottom line.”
Listen at 25:48
ElectroMed revenue grew at approximately 15% annually over five years.
“revenue increasing on a very consistent basis with a compound and annual growth rate kegger at 15 over the past five years”
Listen at 28:11
ElectroMed’s share count has declined because repurchases exceeded issuance.
“the share count has actually declined as the company has bought back more shares than it's issued”
Listen at 28:46
ElectroMed’s fiscal 2026 fourth-quarter revenue growth slowed meaningfully.
“It is a meaningful slowdown.”
Listen at 29:28
ElectroMed’s fiscal 2027 growth is expected to be low double-digit.
“I would expect low double-digit growth compared to the 15.3% for fiscal 2026.”
Listen at 32:10
ElectroMed’s reliance on SmartVest creates material product concentration risk.
“the reliance on one product, SmartVest. This creates a concentration risk.”
Listen at 32:32
Medicare and Medicaid reimbursement changes could materially affect ElectroMed.
“Medicare and Medicaid changes can meaningfully impact Electromed.”
Listen at 32:46
ElectroMed is an appealing long-term investment.
“Overall, ElectroMed is an appealing investment.”
Listen at 35:03
Debt-funded acquisition strategies can raise net debt-to-EBITDA to approximately three times.
“Taking on tons of debt, making acquisitions, getting up to a trailing net debt to EBITDA or forward net debt to EBITDA three times.”
Listen at 38:33
Debt-funded acquisition programs can become financially undisciplined and dilutive.
“It can just get sloppy.”
Listen at 39:08
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.